123 related articles for article (PubMed ID: 7557882)
21. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
22. Activation of PTHrP gene expression in squamous carcinoma cell lines by mutant isoforms of the tumor suppressor p53.
Foley J; King CS; Jiménez JA; Wysolmerski JJ; Philbrick WM
Oncol Res; 2000; 12(2):71-81. PubMed ID: 11132926
[TBL] [Abstract][Full Text] [Related]
23. Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B.
Yam JW; Chan KW; Hsiao WL
Oncogene; 2001 Jan; 20(1):58-68. PubMed ID: 11244504
[TBL] [Abstract][Full Text] [Related]
24. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
[TBL] [Abstract][Full Text] [Related]
25. TP53 and hepatocellular carcinoma.
Puisieux A; Ozturk M
Pathol Biol (Paris); 1997 Dec; 45(10):864-70. PubMed ID: 9769950
[TBL] [Abstract][Full Text] [Related]
26. Differential in situ hybridization for determination of mutational specific expression of the p53 gene in human hepatoma cell lines.
Lin Y; Ong LK; Chan SH
Pathology; 1995 Apr; 27(2):191-6. PubMed ID: 7567152
[TBL] [Abstract][Full Text] [Related]
27. A mutated p53 gene alters thyroid cell differentiation.
Battista S; Martelli ML; Fedele M; Chiappetta G; Trapasso F; De Vita G; Battaglia C; Santoro M; Viglietto G; Fagin JA
Oncogene; 1995 Nov; 11(10):2029-37. PubMed ID: 7478522
[TBL] [Abstract][Full Text] [Related]
28. A codon 248 p53 mutation retains tumor suppressor function as shown by enhancement of tumor growth by antisense p53.
Mukhopadhyay T; Roth JA
Cancer Res; 1993 Sep; 53(18):4362-6. PubMed ID: 8364931
[TBL] [Abstract][Full Text] [Related]
29. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells.
Tamura T; Aoyama N; Saya H; Haga H; Futami S; Miyamoto M; Koh T; Ariyasu T; Tachi M; Kasuga M
Oncogene; 1995 Nov; 11(10):1939-46. PubMed ID: 7478511
[TBL] [Abstract][Full Text] [Related]
30. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.
Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC
Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905
[TBL] [Abstract][Full Text] [Related]
31. Aflatoxin B1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene.
Hulla JE; Chen ZY; Eaton DL
Cancer Res; 1993 Jan; 53(1):9-11. PubMed ID: 8380129
[TBL] [Abstract][Full Text] [Related]
32. mRNA and protein expression of p53 mutations in human bladder cancer cell lines.
Kawasaki T; Tomita Y; Watanabe R; Tanikawa T; Kumanishi T; Sato S
Cancer Lett; 1994 Jul; 82(1):113-21. PubMed ID: 8033064
[TBL] [Abstract][Full Text] [Related]
33. Reexpression of thyroid peroxidase in a derivative of an undifferentiated thyroid carcinoma cell line by introduction of wild-type p53.
Fagin JA; Tang SH; Zeki K; Di Lauro R; Fusco A; Gonsky R
Cancer Res; 1996 Feb; 56(4):765-71. PubMed ID: 8631011
[TBL] [Abstract][Full Text] [Related]
34. Role of activated c-H-ras oncogene in the induction and progression of immortal liver epithelial cell lines derived from normal C3H mice.
Lee GH; Sakai R; Nagao M; Kitagawa T
Int J Cancer; 1991 Jan; 47(1):60-5. PubMed ID: 1985880
[TBL] [Abstract][Full Text] [Related]
35. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
36. Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate.
Chen YM; Chen PL; Arnaiz N; Goodrich D; Lee WH
Oncogene; 1991 Oct; 6(10):1799-805. PubMed ID: 1923505
[TBL] [Abstract][Full Text] [Related]
37. P53-mediated radioresistance does not correlate with metastatic potential in tumorigenic rat embryo cell lines following oncogene transfection.
Bristow RG; Brail L; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):341-55. PubMed ID: 8567335
[TBL] [Abstract][Full Text] [Related]
38. Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 Val-Ala) p53.
Rauth S; Green A; Kichina J; Shilkaitis A
Br J Cancer; 1998 Jun; 77(12):2215-22. PubMed ID: 9649136
[TBL] [Abstract][Full Text] [Related]
39. Malignant transformation of human fibroblast cell strain MSU-1.1 by N-methyl-N-nitrosourea: evidence of elimination of p53 by homologous recombination.
Boley SE; McManus TP; Maher VM; McCormick JJ
Cancer Res; 2000 Aug; 60(15):4105-11. PubMed ID: 10945617
[TBL] [Abstract][Full Text] [Related]
40. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
Cerutti P; Hussain P; Pourzand C; Aguilar F
Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
